The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years

被引:28
作者
Gallo, RC [1 ]
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
关键词
D O I
10.1016/S0140-6736(05)67395-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1894 / 1898
页数:5
相关论文
共 42 条
[11]   Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates [J].
Devico, A ;
Silver, A ;
Thornton, AM ;
Sarngadharan, MG ;
Pal, R .
VIROLOGY, 1996, 218 (01) :258-263
[12]   TAT PROTEIN OF HIV-1 STIMULATES GROWTH OF CELLS DERIVED FROM KAPOSIS-SARCOMA LESIONS OF AIDS PATIENTS [J].
ENSOLI, B ;
BARILLARI, G ;
SALAHUDDIN, SZ ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1990, 345 (6270) :84-86
[13]   BIOLOGICALLY DIVERSE MOLECULAR VARIANTS WITHIN A SINGLE HIV-1 ISOLATE [J].
FISHER, AG ;
ENSOLI, B ;
LOONEY, D ;
ROSE, A ;
GALLO, RC ;
SAAG, MS ;
SHAW, GM ;
HAHN, BH ;
WONGSTAAL, F .
NATURE, 1988, 334 (6181) :444-447
[14]   Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques [J].
Fouts, T ;
Godfrey, K ;
Bobb, K ;
Montefiori, D ;
Hanson, CV ;
Kalyanaraman, VS ;
DeVico, A ;
Pal, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11842-11847
[15]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[16]   Tat as one key to HIV-induced immune pathogenesis and Pat toroid as an important component of a vaccine [J].
Gallo, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8324-8326
[17]  
Gallo RC, 2004, SCIENCE, V305, P179
[18]   AIDS - Diversity considerations in HIV-1 vaccine selection [J].
Gaschen, B ;
Taylor, J ;
Yusim, K ;
Foley, B ;
Gao, F ;
Lang, D ;
Novitsky, V ;
Haynes, B ;
Hahn, BH ;
Bhattacharya, T ;
Korber, B .
SCIENCE, 2002, 296 (5577) :2354-2360
[19]   Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: A 30-month follow-up report [J].
Gringeri, A ;
Santagostino, E ;
Cusini, M ;
MucaPerja, M ;
Marinoni, A ;
Mannucci, PM ;
Burny, A ;
Criscuolo, M ;
Lu, W ;
Andrieru, JM ;
Mbika, JP ;
Lachgar, A ;
Fall, LS ;
Chams, V ;
Feldman, M ;
Hermans, P ;
Zagury, JF ;
Bizzini, B ;
Musicco, M ;
Zagury, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (01) :55-67
[20]   GENOMIC DIVERSITY OF THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME VIRUS HTLV-III - DIFFERENT VIRUSES EXHIBIT GREATEST DIVERGENCE IN THEIR ENVELOPE GENES [J].
HAHN, BH ;
GONDA, MA ;
SHAW, GM ;
POPOVIC, M ;
HOXIE, JA ;
GALLO, RC ;
WONGSTAAL, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (14) :4813-4817